IPO Trending
INNOVACAPEQ / NSE, BSEListed

Innova Captab Limited

Incorporated in January 2005, Innova Captab Limited is a pharmaceutical company operating in three verticals – Contract Development & Manufacturing (CDMO), domestic branded generics, and international branded generics. The company manufactures a wide range of pharmaceutical products including tablets, capsules, dry syrups, injections, ointments and liquid medicines. In FY23 and Q1FY24, the company produced and sold over 600 generic products. Its domestic brands are sold through 5,000+ distributors and ~1.5 lakh retail pharmacies in India. The company also exports branded generics to 20 countries. As of October 31, 2023, Innova Captab employed 29 scientists and engineers, and has its plant in Baddi, Haryana.

₹426 - ₹44856.33x sub
Listed Price452.10
Listing Gain+0.92%
Review-Analyst Consensus Verdict

May apply

No review summary is available yet.

Apply
00%
May Apply
00%
Neutral
00%
Avoid
00%
Not Rated
00%
No IPO review records are available for this issue yet.